Related Experiment Video
Updated: Jul 8, 2025

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
Breast carcinoma presenting with upper limb lymphedema - A rare case
Chandan Kumar Jha1, Upasna Sinha2, Mainak Sinha1
1Department of General Surgery, All India Institute of Medical Sciences, Patna, India.
Breast cancer can cause lymphedema (LE) through axillary lymph node involvement, even without bulky nodes. This case highlights the importance of imaging for diagnosing breast cancer when lymphedema is present.
Area of Science:
- Oncology
- Lymphedema Research
- Diagnostic Imaging
Background:
- Lymphedema (LE) commonly arises post-breast cancer treatment (surgery, radiation).
- Axillary lymph node involvement by breast cancer can cause lymphatic obstruction and LE.
- LE presentation due to direct lymph node metastasis is infrequently reported.
Observation:
- A 50-year-old female presented with right upper limb lymphedema.
- Clinical examination revealed a suspicious breast mass but no bulky axillary lymphadenopathy.
- Breast edema complicated the initial clinical diagnosis of breast cancer.
Findings:
- Lymphoscintigraphy confirmed right upper limb lymphedema.
- Contralateral epitrochlear lymph node uptake suggested pre-existing subclinical lymphedema.
- Right breast carcinoma was diagnosed, with lymphatic involvement causing clinical lymphedema.
Implications:
- Early and thorough imaging (mammography, ultrasound, MRI, PET) is crucial for breast cancer diagnosis when lymphedema is present.
- Breast cancer diagnosis can be challenging with concurrent breast edema.
- This case underscores the diverse presentations of lymphedema in breast cancer patients.
More Related Videos
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024